Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Richard F Pollock, Anne-Marie Kappelgaard & Lisa Seitz. (2015) An analysis of product wastage arising from dosing increment granularity in four modern growth hormone administration devices. Expert Opinion on Drug Delivery 12:3, pages 353-360.
Read now
Read now
Richard F Pollock, Yujun Qian, Tami Wisniewski, Lisa Seitz & Anne-Marie Kappelgaard. (2013) Product wastage from modern human growth hormone administration devices: a laboratory and computer simulation analysis. Medical Devices: Evidence and Research 6, pages 107-114.
Read now
Read now
Articles from other publishers (27)
Beverly M K Biller, Charlotte Höybye, Jean-Marc Ferran, Nicky Kelepouris, Navid Nedjatian, Anne Helene Olsen, Matthias M Weber & Murray B Gordon. (2023) Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER. Journal of the Endocrine Society 7:6.
Crossref
Crossref
Philippe Backeljauw, Joanne C Blair, Jean-Marc Ferran, Nicky Kelepouris, Bradley S Miller, Alberto Pietropoli, Michel Polak, Lars Sävendahl, Franciska Verlinde & Tilman R Rohrer. (2023) Early GH Treatment Is Effective and Well Tolerated in Children With Turner Syndrome: NordiNet® IOS and Answer Program. The Journal of Clinical Endocrinology & Metabolism.
Crossref
Crossref
Judith Ross, Moshe Fridman, Nicky Kelepouris, Kristine Murray, Nils Krone, Michel Polak, Tilman R Rohrer, Alberto Pietropoli, Neil Lawrence & Philippe Backeljauw. (2023) Factors Associated With Response to Growth Hormone in Pediatric Growth Disorders: Results of a 5-year Registry Analysis. Journal of the Endocrine Society 7:5.
Crossref
Crossref
Parisa Eslami, Fatemeh Sayarifard, Reza Safdari, Leila Shahmoradi & Zahra Karbasi. (2022) Global perspective on pediatric growth hormone registries: a systematic review. Journal of Pediatric Endocrinology and Metabolism 35:6, pages 709-726.
Crossref
Crossref
Tal Ben-Ari, Gabriel Chodick, Varda Shalev, Dalit Goldstein, Roy Gomez & Zohar Landau. (2021) Real-World Treatment Patterns and Outcomes of Growth Hormone Treatment Among Children in Israel Over the Past Decade (2004–2015). Frontiers in Pediatrics 9.
Crossref
Crossref
Beverly M. K. Biller, Charlotte Höybye, Paul Carroll, Murray B. Gordon, Anna Camilla Birkegård, Nicky Kelepouris, Navid Nedjatian & Matthias M. Weber. (2021) Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program. Pituitary 24:4, pages 611-621.
Crossref
Crossref
Lars Sävendahl, Michel Polak, Philippe Backeljauw, Joanne C Blair, Bradley S Miller, Tilman R Rohrer, Anita Hokken-Koelega, Alberto Pietropoli, Nicky Kelepouris & Judith Ross. (2021) Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER. The Journal of Clinical Endocrinology & Metabolism 106:6, pages 1728-1741.
Crossref
Crossref
Moris Angulo, M. Jennifer Abuzzahab, Alberto Pietropoli, Vlady Ostrow, Nicky Kelepouris & Maithe Tauber. (2020) Outcomes in children treated with growth hormone for Prader-Willi syndrome: data from the ANSWER Program® and NordiNet® International Outcome Study. International Journal of Pediatric Endocrinology 2020:1.
Crossref
Crossref
Bradley S. Miller, Judith Ross & Vlady Ostrow. (2020) Height outcomes in children with growth hormone deficiency and idiopathic short stature treated concomitantly with growth hormone and aromatase inhibitor therapy: data from the ANSWER program. International Journal of Pediatric Endocrinology 2020:1.
Crossref
Crossref
Matthias M. Weber, Murray B. Gordon, Charlotte Höybye, Jens Otto L. Jørgensen, Gediminas Puras, Vera Popovic-Brkic, Mark E. Molitch, Vlady Ostrow, Natalia Holot, Alberto Pietropoli & Beverly M.K. Biller. (2020) Growth hormone replacement in adults: Real-world data from two large studies in US and Europe. Growth Hormone & IGF Research 50, pages 71-82.
Crossref
Crossref
Lars Sävendahl, Michel Polak, Philippe Backeljauw, Jo Blair, Bradley S Miller, Tilman R Rohrer, Alberto Pietropoli, Vlady Ostrow & Judith Ross. (2019) Treatment of Children With GH in the United States and Europe: Long-Term Follow-Up From NordiNet® IOS and ANSWER Program. The Journal of Clinical Endocrinology & Metabolism 104:10, pages 4730-4742.
Crossref
Crossref
Young-Jun Rhie, Jae-Ho Yoo, Jin-Ho Choi, Hyun-Wook Chae, Jae Hyun Kim, Sochung Chung, Il Tae Hwang, Choong Ho Shin, Eun Young Kim & Ho-Seong Kim. (2019) Long-term safety and effectiveness of growth hormone therapy in Korean children with growth disorders: 5-year results of LG Growth Study. PLOS ONE 14:5, pages e0216927.
Crossref
Crossref
G. Migliaretti, S. Ditaranto, C. Guiot, S. Vannelli, P. Matarazzo, N. Cappello, I. Stura & F. Cavallo. (2018) Long-term response to recombinant human growth hormone treatment: a new predictive mathematical method. Journal of Endocrinological Investigation 41:7, pages 839-848.
Crossref
Crossref
Michel Polak, Daniel Konrad, Birgitte Tønnes Pedersen, Gediminas Puras & Marta Šnajderová. (2018)
Still too little, too late? Ten years of growth hormone therapy baseline data from the NordiNet
®
International Outcome Study
. Journal of Pediatric Endocrinology and Metabolism 31:5, pages 521-532.
Crossref
Crossref
Kirstine Stochholm & Wieland Kiess. (2018) Long-term safety of growth hormone-A combined registry analysis. Clinical Endocrinology 88:4, pages 515-528.
Crossref
Crossref
Sochung Chung, Jae-Ho Yoo, Jin Ho Choi, Young-Jun Rhie, Hyun-Wook Chae, Jae Hyun Kim, Il Tae Hwang, Choong Ho Shin, Eun Young Kim & Kee-Hyoung Lee. (2018) Design of the long-term observational cohort study with recombinant human growth hormone in Korean children: LG Growth Study. Annals of Pediatric Endocrinology & Metabolism 23:1, pages 43-50.
Crossref
Crossref
Charlotte Höybye, Matthias M. Weber, Effie Pournara, Birgitte Tønnes Pedersen & Beverly M. K. Biller. (2017)
Is GH dosing optimal in female patients with adult-onset GH deficiency? An analysis from the NordiNet
®
International Outcome Study
. Clinical Endocrinology 86:6, pages 798-805.
Crossref
Crossref
Matthias M. Weber, Beverly M.K. Biller, Birgitte Tønnes Pedersen, Effie Pournara, Jens Sandahl Christiansen & Charlotte Höybye. (2016)
The effect of growth hormone (
GH
) replacement on blood glucose homeostasis in adult nondiabetic patients with
GH
deficiency: real‐life data from the NordiNet
®
International Outcome Study
. Clinical Endocrinology 86:2, pages 192-198.
Crossref
Crossref
Ulla Feldt-Rasmussen & Marianne Klose. (2016) Central hypothyroidism and its role for cardiovascular risk factors in hypopituitary patients. Endocrine 54:1, pages 15-23.
Crossref
Crossref
Henrik Thybo Christesen, Birgitte Tønnes Pedersen, Effie Pournara, Isabelle Oliver Petit & Pétur Benedikt Júlíusson. (2016) Short Stature: Comparison of WHO and National Growth Standards/References for Height. PLOS ONE 11:6, pages e0157277.
Crossref
Crossref
Lars Sävendahl, Effie Pournara, Birgitte Tønnes Pedersen & Oliver Blankenstein. (2016) Is safety of childhood growth hormone therapy related to dose? Data from a large observational study. European Journal of Endocrinology 174:5, pages 681-691.
Crossref
Crossref
MurrayB. Gordon, RichardA. Levy, Robert. Gut & John. Germak. (2016) Trends In Growth Hormone Stimulation Testing And Growth Hormone Dosing In Adult Growth Hormone Deficiency Patients: Results From The Answer Program. Endocrine Practice 22:4, pages 396-405.
Crossref
Crossref
Peter A. Lee, Judith L. Ross, Birgitte Tønnes Pedersen, Primoz Kotnik, John A. Germak & Henrik T. Christesen. (2015) Noonan syndrome and Turner syndrome patients respond similarly to 4 years’ growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program. International Journal of Pediatric Endocrinology 2015:1.
Crossref
Crossref
Judith L Ross, Peter A Lee, Robert Gut & John Germak. (2015) Increased height standard deviation scores in response to growth hormone therapy to near-adult height in older children with delayed skeletal maturation: results from the ANSWER Program. International Journal of Pediatric Endocrinology 2015:1.
Crossref
Crossref
Susan R. Rose, Grafton Reeves, Robert Gut & John Germak. (2015) Attention-Deficit/Hyperactivity Disorder Medication Treatment Impact on Response to Growth Hormone Therapy: Results from the ANSWER Program, a Non-Interventional Study. The Journal of Pediatrics 167:6, pages 1389-1396.
Crossref
Crossref
Judith L. Ross, Peter A. Lee, Robert Gut & John Germak. (2015) Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years. Growth Hormone & IGF Research 25:6, pages 286-293.
Crossref
Crossref
Oliver Blankenstein, Birgitte Tønnes Pedersen, Michael Schlumpf, Arne Haahr Andreasen & Pétur Benedikt Júlíusson. (2015) Management and interpretation of heterogeneous observational data: Using insulin-like growth factor-I data from the NordiNet® International Outcome Study. Growth Hormone & IGF Research 25:1, pages 41-46.
Crossref
Crossref